Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis)
Clinical trial NCT00145327 · COMPLETED
Trial details
- NCT number
- NCT00145327
- Sponsor
- Novartis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-05-01
- Primary completion
- 2009-11-01
- Enrollment
- 2456
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.